Introduced:
Apr 30, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
2
Actions
2
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Apr 30, 2025
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2719: 1)
Actions (2)
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2719: 1)
Type: IntroReferral
| Source: Senate
Apr 30, 2025
Introduced in Senate
Type: IntroReferral
| Source: Library of Congress
| Code: 10000
Apr 30, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (2)
(D-NJ)
Apr 30, 2025
Apr 30, 2025
(R-ID)
Apr 30, 2025
Apr 30, 2025
Full Bill Text
Length: 2,906 characters
Version: Introduced in Senate
Version Date: Apr 30, 2025
Last Updated: Nov 19, 2025 6:26 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 194 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. RES. 194
Expressing support for the designation of the month of April 2025 as
``Parkinson's Awareness Month''.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 30, 2025
Mr. Scott of Florida (for himself, Mr. Booker, and Mr. Risch) submitted
the following resolution; which was referred to the Committee on
Health, Education, Labor, and Pensions
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of the month of April 2025 as
``Parkinson's Awareness Month''.
Whereas Parkinson's disease--
(1) affects over 1,000,000 individuals in the United States with nearly
90,000 individuals diagnosed each year;
(2) is the fastest-growing and second most common neurodegenerative
disease in the world;
(3) is believed to be caused by a combination of genetic and
environmental factors, but the exact cause in most individuals is still
unknown; and
(4) is the 15th leading cause of death in the United States, according
to the Centers for Disease Control and Prevention;
Whereas, by the year 2037, it is estimated that the number of individuals in the
United States with Parkinson's disease will nearly double, and
Parkinson's disease will cost the United States at least $80,000,000,000
annually;
Whereas the symptoms of Parkinson's disease can include dementia and cognitive
impairment, tremors, slowness of movement and rigidity, gait and balance
difficulties, speech and swallowing difficulties, depression, and a
variety of other symptoms;
Whereas there are millions of family caregivers, friends, and loved ones whose
lives are greatly affected by Parkinson's disease; and
Whereas more research, education, and community support services are needed--
(1) to find better treatments and a cure for Parkinson's disease; and
(2) to maintain the dignity of individuals living with Parkinson's
disease: Now, therefore, be it
Resolved, That the Senate--
(1) expresses support for the designation of the month of
April 2025 as ``Parkinson's Awareness Month'';
(2) supports the goals and ideals of Parkinson's Awareness
Month;
(3) continues to support research to find better treatments
and a cure for Parkinson's disease;
(4) recognizes the individuals living with Parkinson's
disease who participate in vital clinical trials to advance the
knowledge of the disease; and
(5) commends the dedication of organizations, volunteers,
researchers, and millions of individuals across the United
States working to improve the quality of life of people living
with Parkinson's disease and their families.
<all>
[From the U.S. Government Publishing Office]
[S. Res. 194 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. RES. 194
Expressing support for the designation of the month of April 2025 as
``Parkinson's Awareness Month''.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 30, 2025
Mr. Scott of Florida (for himself, Mr. Booker, and Mr. Risch) submitted
the following resolution; which was referred to the Committee on
Health, Education, Labor, and Pensions
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of the month of April 2025 as
``Parkinson's Awareness Month''.
Whereas Parkinson's disease--
(1) affects over 1,000,000 individuals in the United States with nearly
90,000 individuals diagnosed each year;
(2) is the fastest-growing and second most common neurodegenerative
disease in the world;
(3) is believed to be caused by a combination of genetic and
environmental factors, but the exact cause in most individuals is still
unknown; and
(4) is the 15th leading cause of death in the United States, according
to the Centers for Disease Control and Prevention;
Whereas, by the year 2037, it is estimated that the number of individuals in the
United States with Parkinson's disease will nearly double, and
Parkinson's disease will cost the United States at least $80,000,000,000
annually;
Whereas the symptoms of Parkinson's disease can include dementia and cognitive
impairment, tremors, slowness of movement and rigidity, gait and balance
difficulties, speech and swallowing difficulties, depression, and a
variety of other symptoms;
Whereas there are millions of family caregivers, friends, and loved ones whose
lives are greatly affected by Parkinson's disease; and
Whereas more research, education, and community support services are needed--
(1) to find better treatments and a cure for Parkinson's disease; and
(2) to maintain the dignity of individuals living with Parkinson's
disease: Now, therefore, be it
Resolved, That the Senate--
(1) expresses support for the designation of the month of
April 2025 as ``Parkinson's Awareness Month'';
(2) supports the goals and ideals of Parkinson's Awareness
Month;
(3) continues to support research to find better treatments
and a cure for Parkinson's disease;
(4) recognizes the individuals living with Parkinson's
disease who participate in vital clinical trials to advance the
knowledge of the disease; and
(5) commends the dedication of organizations, volunteers,
researchers, and millions of individuals across the United
States working to improve the quality of life of people living
with Parkinson's disease and their families.
<all>